SCHEMBL6288504

SCHEMBL6288504

CCOC(=O)/C(=N\N)C(=O)c1cc(I)cnc1Cl

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.37
NPSR1 Q6W5P4 2/20 0.34
HPGD P15428 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
NPC1 O15118 2/20 0.33
HTT P42858 2/20 0.33
TP53 P04637 1/20 0.33
XBP1 P17861 1/20 0.33
MAPK1 P28482 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TLR9 Q9NR96 1/20 0.33
DPP4 P27487 2/20 0.32
LMNA P02545 1/20 0.32
GPR35 Q9HC97 1/20 0.31
KDM4E B2RXH2 1/20 0.31
GABRA1 P14867 1/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6288505 1.00 ABCB1 (0.37) ABCB1NPSR1HPGDALDH1A1MAPT
SCHEMBL9383978 0.77 CASP1 (0.47) HPGDALDH1A1HTTKDM4EGABRA1
SCHEMBL3977484 0.76 NPSR1 (0.43) NPSR1HPGDALDH1A1MAPTMAPK1
SCHEMBL3977483 0.76 NPSR1 (0.43) NPSR1HPGDALDH1A1MAPTMAPK1
SCHEMBL28522607 0.70 ALDH1A1 (0.46) ALDH1A1MAPTNPC1TP53MAPK1
SCHEMBL3710783 0.68 CYP11B1 (0.40) ABCB1NPSR1ALDH1A1MAPTMAPK1
SCHEMBL1505507 0.67 OPRK1 (0.46) ALDH1A1KDM4E
SCHEMBL21596476 0.67 OPRK1 (0.40) NPSR1ALDH1A1NPC1TP53MAPK1
SCHEMBL18531379 0.66 ALOX15 (0.46) ABCB1NPSR1ALDH1A1MAPTHSD17B10
SCHEMBL3716153 0.66 CES2 (0.47) NPSR1HPGDALDH1A1MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6903097-B2 Heterocycle carboxamides as antiviral agents PHARMACIA & UPJOHN COMPANY (US) 2005-06-07 US disclosed
US-20040142928-A1 Heterocycle carboxamides as antiviral agents BUNDY GORDON L (US) 2004-07-22 US disclosed
US-20030207880-A1 Heterocycle carboxamides as antiviral agents BUNDY GORDON L (US) 2003-11-06 US disclosed
US-6559145-B2 Herpes virus PHARMACIA & UPJOHN COMPANY 2003-05-06 US disclosed
EP-1301493-A2 HETEROCYCLE CARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2003-04-16 EP disclosed
US-20020025960-A1 Heterocycle carboxamides as antiviral agents PHARMACIA & UPJOHN COMPANY 2002-02-28 US disclosed
WO-2002004444-A2 HETEROCYCLE CARBOXAMIDES AS ANTIVIRAL AGENTS PHARMACIA & UPJOHN COMPANY (US) 2002-01-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142928-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 ABCB1 2146/4885NPSR1 3747/4885HPGD 1618/4885
US-20020025960-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 ABCB1 2146/4885NPSR1 3747/4885HPGD 1618/4885
US-20030207880-A1 Heterocycle carboxamides as antiviral agents ZC3HAV1, ZC3HAV1L, HDAC1 ABCB1 2146/4885NPSR1 3747/4885HPGD 1618/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.